European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and pharmaceutical company Ascendis Pharma (ASND), which rose 1.4% and 1.1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biotech firm BioNTech (BNTX), which were up 0.8% and 0.2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Genfit (GNFT), which fell 6.3% and 5.4% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and financial services company Banco Santander (SAN), which dropped 2.8% and 2.5% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which surged 13.5% and 13.3% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which rose 13.3% and 4.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Verona Pharma (VRNA), which lost 2% and 2.8% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and mining company BHP Group (BHP), which were down 2.2% and 3.1% respectively.